Last week, the Biotech industry hasn't moved much but MorphoSys is up 7.0% in that time. As for the longer term, the industry has declined 7.2% in the last year. Looking forward, earnings are forecast to grow by 42% annually.
Has the German Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 07 Jun 2023 | €4.1b | €967.4m | -€212,660,026.00 | 31.4x | -19.3x | 4.2x |
Fri, 05 May 2023 | €3.7b | €966.0m | -€194,145,453.00 | 30x | -19x | 3.8x |
Sun, 02 Apr 2023 | €3.5b | €920.1m | -€215,284,148.00 | 13.9x | -16.1x | 3.8x |
Tue, 28 Feb 2023 | €3.0b | €612.2m | -€74,677,325.00 | 10.8x | -40.1x | 4.9x |
Thu, 26 Jan 2023 | €3.0b | €611.9m | -€53,407,435.00 | 11.1x | -56.7x | 4.9x |
Sat, 24 Dec 2022 | €3.0b | €611.9m | -€53,407,435.00 | 11x | -56.3x | 4.9x |
Mon, 21 Nov 2022 | €3.0b | €611.8m | -€48,604,435.00 | 10.6x | -60.9x | 4.8x |
Wed, 19 Oct 2022 | €2.6b | €627.4m | -€129,805,157.00 | 5.3x | -19.7x | 4.1x |
Fri, 16 Sep 2022 | €2.6b | €627.4m | -€129,805,157.00 | 6.1x | -20.3x | 4.2x |
Sun, 14 Aug 2022 | €2.8b | €605.5m | -€122,397,513.00 | 6.3x | -22.5x | 4.5x |
Tue, 12 Jul 2022 | €3.4b | €772.2m | -€724,268,362.00 | n/a | -4.7x | 4.4x |
Thu, 09 Jun 2022 | €3.4b | €768.8m | -€724,082,241.00 | n/a | -4.8x | 4.5x |
Sat, 07 May 2022 | €3.3b | €798.7m | -€685,603,111.00 | 1.6x | -4.8x | 4.1x |
Mon, 04 Apr 2022 | €3.7b | €808.9m | -€704,269,813.00 | n/a | -5.2x | 4.6x |
Wed, 02 Mar 2022 | €3.6b | €789.6m | -€311,283,353.00 | n/a | -11.4x | 4.5x |
Fri, 28 Jan 2022 | €3.7b | €789.6m | -€311,283,353.00 | n/a | -11.8x | 4.6x |
Sun, 26 Dec 2021 | €4.1b | €789.6m | -€311,690,565.00 | n/a | -13.1x | 5.2x |
Tue, 23 Nov 2021 | €4.2b | €789.6m | -€311,690,565.00 | n/a | -13.6x | 5.4x |
Thu, 21 Oct 2021 | €4.4b | €771.2m | -€257,628,521.00 | n/a | -17.3x | 5.8x |
Sat, 18 Sep 2021 | €4.4b | €762.9m | -€163,686,446.00 | 1.3x | -26.6x | 5.7x |
Mon, 16 Aug 2021 | €4.2b | €769.4m | -€175,243,228.00 | 1.4x | -23.9x | 5.4x |
Mon, 31 May 2021 | €5.0b | €742.3m | -€215,931,793.00 | 1.3x | -23x | 6.7x |
Thu, 04 Mar 2021 | €5.7b | €929.7m | -€78,349,962.23 | 27.9x | -72.9x | 6.1x |
Sun, 06 Dec 2020 | €5.4b | €857.0m | -€138,041,722.02 | 68x | -39.1x | 6.3x |
Wed, 09 Sep 2020 | €6.2b | €856.0m | -€124,654,217.95 | 32.8x | -49.7x | 7.2x |
-48.5x
How does German Biotech compare with similar industries?
DE Market | 0.44% | |
Healthcare | 1.56% | |
Biotech | 0.54% | |
Biotech | 0.54% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MOR MorphoSys | €26.78 | 12.7% +€102.8m | 32.6% | PS3.1x | |
VSC 4SC | €3.90 | 25.0% +€7.9m | 108.6% | PS90.5x | |
PA8 Paion | €6.25 | 12.6% +€5.0m | -32.1% | PS1.3x | |
20B BioMark Diagnostics | €0.21 | 17.5% +€2.6m | 4.0% | PS180.2x | |
ELN Elanix Biotechnologies | €0.05 | 9,900.0% +€400.0k | -66.7% | n/a |